|
Arena Pharmaceuticals, Inc.
|
| Link ID |
246353 |
| Title |
Arena Pharmaceuticals, Inc. |
| Url |
http://www.arenapharm.com/ |
| Description |
Receptor-based drug discovery in the fields of diabetes, obesity, cardiovascular, sleep disorders, neurodegeneration, schizophrenia, depression and anxiety. Comprehensive profile of company in San Diego, California. (Nasdaq: ARNA) |
| Category |
Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Research and Development |
| Keywords |
|
| Date |
Jul 19, 2006 |
| Contact Name |
|
| Email |
|
Add to My Favorite
Refer it to Friend
Report Broken Link
|
|
Other links at Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Research and Development |
| 1. |
MannKind Corp.
|
|
|
Developing a pulmonary insulin delivery system, and immunotherapy of cancer, by identifying tumor-related antigens, DNA and peptide-based drugs evoking cell-mediated responses. Located in Valencia, California.
|
| 2. |
Curis, Inc
|
|
|
Developing small molecule and peptide drugs in regulatory signaling and regenerative pathways. Introduces technical background, product pipeline, collaborations, investment data and careers headquartered from Cambridge, Massachusetts. (Nasdaq: CVGP)
|
| 3. |
Xenova Group plc
|
|
|
Holding company for drug discovery subsidiaries, developing anti-cancer compounds in clinical stage, and addiction vaccines. Includes candidates for therapeutic focus, investor details, with contacts in Slough and Cambridge, England. (Nasdaq: XNVA)
|
| 4. |
Intra-Cellular Therapies, Inc.
|
|
|
Developing novel drugs against targets inside nerve cells to treat CNS disorders. Includes therapeutic projects, target biochemistry, corporate data and contacts for headquarters in New York City.
|
| 5. |
Hemobiotech Inc.
|
|
|
Developer of blood substitute, aiming to address intrinsic hemoglobin toxicity. Introduction to company and their work, with form to contact Dallas, Texas.
|
|
|
